Gerald Bindert-Schmid
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Correction: White paper on identification, information, and eligibility assessment of potential participants in lung cancer screening in Germany
Journal: Pneumologie (Stuttgart, Germany)
Published: November 17, 2025
White paper on identification, information, and eligibility assessment of potential participants in lung cancer screening in Germany
Journal: Pneumologie (Stuttgart, Germany)
Published: October 14, 2025
Incidental Pulmonary Nodules: What Should We Do in 2026?
Journal: Respiration; international review of thoracic diseases
Published: May 08, 2025
Effectiveness of NELSON versus PLCOm2012 lung cancer screening eligibility criteria in Germany (HANSE): a prospective cohort study.
Journal: The Lancet. Oncology
Published: April 22, 2025
FDG-PET/CT based small volume accelerated immuno chemoradiotherapy in locally advanced NSCLC (PACCELIO) - a randomized, open-label, multicenter phase II trial protocol.
Journal: BMC cancer
Published: December 12, 2024
Design and Rationale of the HANSE Study: A Holistic German Lung Cancer Screening Trial Using Low-Dose Computed Tomography.
Journal: RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin
Published: August 02, 2022
Incidental Pulmonary Nodules - What Do We Know in 2022.
Journal: Respiration; international review of thoracic diseases
Published: May 25, 2022
Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66].
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 28, 2022
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 14, 2021
A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer.
Journal: Therapeutic advances in medical oncology
Published: November 08, 2020
Protocol of a Randomized Controlled Study of the PneumRx Endobronchial Coil System versus Standard-of-Care Medical Management in the Treatment of Subjects with Severe Emphysema (ELEVATE).
Journal: Respiration; international review of thoracic diseases
Published: April 25, 2019
Last Updated: 09/26/2026